Under construction – not a live service
Sign in
Taking people in FinlandPhase 3

Ultrasound Study of Brain Blood Flow and Stiffness in Newborns

Uses contrast ultrasound and elastography to study brain blood flow in newborns with brain injury.

Plain-language title generated from the registry record
Registry title: Neonatal Brain Ultrasound With CEUS and Elastography

Key facts

Where
Turku, FinlandSee the site
Phase
Phase 3

Where in Finland

  • Turku University HospitalTurku, FinlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Turku University Hospital
Trial code
NCT05648812
Record updated
15 January 2026
Original description
The aim of our study is to investigate changes of brain perfusion and elasticity in neonates during the time that a neonate is adapting to live outside the womb and during diseases that are suspected to affect neonatal brain perfusion. We use contrast enhanced ultrasound (sulphur hexafluoride) and ultrasound-assisted elastography to evaluate the state of brain perfusion. We will study neonates recruited from the Neonatal Units of Turku University Hospital.Read full original descriptionShow less

Contrast Enhanced Ultrasound and Elastography of the Neonatal Brain

The aim of our study is to investigate changes of brain perfusion and elasticity in neonates during the time that a neonate is adapting to live outside the womb and during diseases that are suspected to affect neonatal brain perfusion. We use contrast enhanced ultrasound (sulphur hexafluoride) and ultrasound-assisted elastography to evaluate the state of brain perfusion. We will study neonates recruited from the Neonatal Units of Turku University Hospital.

Inclusion: Babies less than 7 months treated at the neonatal units of Turku University hospital.

Exclusion: Difficult congenital malformations that need surgical treatment; Pre-known genetic disease; Medical history of SonoVue hypersensitivity; Uncontrolled systemic hypertension; Central nervous system tumors; Weight less than 2,5 kg during examination; Systolic pulmonary artery pressure > 90 mmHg; Unstable cardiovascular state.

ClinicalTrials.gov NCT05648812